Compare GSK plc (GSK) vs iShares Global Clean Energy ETF (ICLN) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
GSK plc vs iShares Global Clean Energy ETF — how do they compare? GSK plc trades at $46.5 (market cap $91.88B), while iShares Global Clean Energy ETF trades at $17.28 (market cap $2.27B). The key difference: GSK plc is far larger — about 40.5× iShares Global Clean Energy ETF's market cap, and GSK plc pays a 3.9% dividend while iShares Global Clean Energy ETF pays none. Which is the better fit depends on your goals — on Pluang, investors hold GSK plc for 93 Days and iShares Global Clean Energy ETF for 87 Days on average.
| GSK | ICLN | |
|---|---|---|
Market Cap | $91.88B | $2.27B |
Volume | 7,730,529 | 6,845,064 |
Sector | Health | — |
52-Week High | $61.18 | $23.75 |
52-Week Low | $43.24 | $15.78 |
Typical Hold Time | 93 Days | 87 Days |
Enterprise Value | $111.88B | — |
Dividend Yield | 3.9% | — |
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
GSK trades at $46.50, down 1.11% with bearish technical signals, though RSI levels suggest potential oversold conditions. Fundamentally, the company shows strong profitability with 72.73% gross margins and consistent earnings beats, while maintaining a reasonable P/E of 14.89. Recent developments include strategic oncology partnerships and a $750M cancer therapy acquisition, positioning for long-term growth despite facing an HIV patent cliff.
GSK presents a mixed investment case with strong fundamentals and pipeline growth offset by technical weakness and patent expiration risks. The company's £40B sales target and cost-saving initiatives provide upside potential, while analyst consensus leans cautious with 55% hold ratings. Key risks include execution of pipeline development and competitive pressures in core markets.
ICLN trades at $17.28, down 0.17% with a bearish technical outlook showing 14 sell signals versus 3 buy signals. The ETF faces headwinds from higher volatility and expense ratios compared to traditional energy ETFs, though clean energy benefits from global renewable energy acceleration driven by geopolitical tensions and data center power demand growth.
The fund's broader diversification across 105 global clean energy companies provides exposure to the energy transition theme, but investors face risks from competitive pressure from higher-yielding traditional energy ETFs and significant historical drawdowns of 57.2% that highlight the sector's volatility.
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
Top news
Latest headlines on both assets
Top news
Latest headlines on both assets
About GSK plc
In the pharmaceutical industry, GSK ranks as one of the largest firms by total sales. The company wields its might across several therapeutic classes, including respiratory, cancer, and antiviral, as well as vaccines. GSK uses joint ventures to gain additional scale in certain markets like HIV.
Read more on GSK →About iShares Global Clean Energy ETF
The index is designed to track the performance of approximately 100 clean energy-related companies. The fund generally invests at least 80% of its assets in the component securities of the target index. The index may invest up to 20% of its assets in certain futures, trading options and swap contracts, cash and cash equivalents, as well as in securities not included in the index. It is non-diversified.
Read more on ICLN →
